Abstract
Precision cancer medicine deals with the selection of anticancer drugs for
treatment that is appropriate for the tumor's molecular profile and that of the tumor
microenvironment. Further, the process of drug development and efficacy analysis
becomes tedious with an improved understanding of genetic profile and pattern. In this
regard, artificial intelligence (AI) has demonstrated enormous potential in several areas
of the healthcare sector that deal with data analysis and drug discovery. AI has
extended towards improving therapeutic efficacy with the integration of AI-based tools
into the cancer care regime. Importantly, with the application of AI algorithms, the
gene mutations' impact on the sensitivity of chemotherapy or radiation therapy can be
predicted. AI-assisted drug identification involving virtual screening of the drug safety
and efficacy is relatively cost-effective and time-saving.
Keywords: Artificial intelligence, Gene therapy, Nanoformulations, Nanomedicine, Personalized medicine, Therapy.